ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2096

Immune Dysregulation in Patients with TRNT1 Deficiency

Angeliki Giannelou1, Qing Zhou2, Hong-Wei Sun3, Dan Yang4, Susan Moir5, Jehad H. Edwan3, Wanxia L. Tsai3, Elisavet Serti6, Monique Stoffels2, Deborah L. Stone7, Amanda K. Ombrello7, Karyl Barron5, Helen C. Su5, Abdullah Al Sonbul8, Sarita Joshi9, Kimberly Risma10, Lucie Sramkova11, Martha M. Quezado12, Katherine Calvo13, Abu-Asab Mones14, Gustavo Gutierrez-Cruz3, Massimo G. Gadina3, Markus Hafner3, Ivona Aksentijevich2,15 and Daniel Kastner2, 1National Human Genome Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2NIH/NHGRI, Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 5National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 6Immunology Section, Liver Diseases Branch, NIDDK, NIH, Bethesda, MD, 7National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 8King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, 9Nationwide Children's Hospital, Columbus, OH, 10Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 11Charles University 2nd Faculty of Medicine and UH Motol, Prague, Czech Republic, 12Laboratory of Pathology/National Cancer Institute, National Institutes of Health, Bethesda, MD, 13Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, 14National Eye Institute, National Institutes of Health, Bethesda, MD, 15Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Autoinflammatory Disease and Gene Expression

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:   Next generation sequencing has led to the discovery of new diseases and molecules regulating immune function. Hypomorphic mutations in the TRNT1 gene cause a syndrome of sideroblastic anemia, immunodeficiency, periodic fevers and developmental delay, also known as SIFD. The TRNT1 enzyme catalyzes an essential step for tRNA maturation and protein synthesis, however, the underlying disease mechanisms are largely unknown. We aim to characterize the mechanisms of inflammation in this disease.

Methods:   Whole exome sequencing or candidate gene screening was performed in two families, each with two affected siblings, and in three sporadic patients. Patient cells and tissue were used for deep RNA and tRNA sequencing, cytokine profiling, immunophenotyping through multicolor flow cytometry, H&E, immunohistochemistry and electron microscopy.  

Results:

We identified seven patients with biallelic missense homozygous or compound heterozygous mutations in TRNT1. Four out of six mutations have not been reported. Three patients died of multiorgan failure. Two apparently unrelated patients shared the same genotype and had similar clinical presentation. Deep sequencing of tRNAs isolated from patients’ fibroblasts showed a significant down-regulation of mature tRNAs when compared to healthy controls. RNA-sequencing of patients’ whole blood revealed up-regulation of neutrophil-related genes. Consistent with these data, lesional biopsies from two patients’ colon showed cryptitis with neutrophilic infiltration. Cultured patients’ macrophages showed increased expression of proinflammatory cytokines IL-6, TNF-a, IL-1b, and accordingly, monocytes displayed increased phosphorylation of STAT3 ex vivo, possibly IL-6 induced, compared to monocytes isolated from healthy donors.  Patients had variable degrees of B cell immunodeficiency with an increased population of immature B cells in the peripheral blood. Four patients had a bone marrow examination that revealed a markedly increased number of immature CD10+ CD20–B cells, and at the same time a decreased mature B cell population. Electron microscopy of BM smears showed evidence for abnormal morphology of blood vessels and endothelial cells, serum leakage and cellular debris in the stroma. Lymphocytes and monocytes displayed abnormal shape and degenerated mitochondria. Three patients have been on treatment with a TNF-a inhibitor that has shown promising results in attenuating the systemic inflammation and stabilizing the anemia.

Conclusion: Hypomorphic mutations in TRNT1 are associated with a new, often severe, autoinflammatory disease manifesting a pleiotropic clinical phenotype. Given the essential function and ubiquitous expression of TRNT1, multiple cell types are affected. Myeloid cells, macrophages and neutrophils, might play an important role in mediating inflammation. Further studies may lead to the discovery of a new pathway regulating immune function.


Disclosure: A. Giannelou, None; Q. Zhou, None; H. W. Sun, None; D. Yang, None; S. Moir, None; J. H. Edwan, None; W. L. Tsai, None; E. Serti, None; M. Stoffels, None; D. L. Stone, None; A. K. Ombrello, None; K. Barron, None; H. C. Su, None; A. Al Sonbul, None; S. Joshi, None; K. Risma, None; L. Sramkova, None; M. M. Quezado, None; K. Calvo, None; A. A. Mones, None; G. Gutierrez-Cruz, None; M. G. Gadina, None; M. Hafner, None; I. Aksentijevich, None; D. Kastner, None.

To cite this abstract in AMA style:

Giannelou A, Zhou Q, Sun HW, Yang D, Moir S, Edwan JH, Tsai WL, Serti E, Stoffels M, Stone DL, Ombrello AK, Barron K, Su HC, Al Sonbul A, Joshi S, Risma K, Sramkova L, Quezado MM, Calvo K, Mones AA, Gutierrez-Cruz G, Gadina MG, Hafner M, Aksentijevich I, Kastner D. Immune Dysregulation in Patients with TRNT1 Deficiency [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/immune-dysregulation-in-patients-with-trnt1-deficiency/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immune-dysregulation-in-patients-with-trnt1-deficiency/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology